Tristan Rousselle photo
MWS EU 2022 Speaker

Tristan Rousselle

  • Aryballe
  • Founder & Deputy CEO
  • Biography

Tristan Rousselle, Founder & Deputy CEO | LinkedIn

Tristan ensures the development of global strategic partnerships and customer relationships to meet Aryballe’s long term vision for the potential of digital olfaction. Prior to founding Aryballe in 2014, Tristan was the founder and CEO of PX’Therapeutics which specialized in the development of therapeutic proteins. PX’Therapeutics was sold to Aguettan Biotech in 2012. Tristan holds a PhD in Cell Biology from Grenoble University (France).

  • Presentation
Developing bio-based sensors on silicon photonics

Digital olfaction mimics the human sense of smell to deliver consistent, objective odor data. To do this, Aryballe uses a proprietary combination of peptide biosensors to detect a wide range of odors. These biosensors are grafted to a silicon surface to deliver a silicon photonics-based solution that is robust and capable of mass production to address a wide range of applications and markets. This presentation will cover the industrialization of this approach along with resulting performance of the sensors generated by this process.

aryballe logo
  • Company Profile

Aryballe

Aryballe combines biochemistry, advanced optics and machine learning to mimic the human sense of smell. Odors captured by the silicon photonics-based core sensor in our NeOse Advance are analyzed by the cloud-based Aryballe Suite to provide objective, fast analysis. This enables customers to leverage odor data for improved decision making for R&D, quality control, and manufacturing.

MWS EU 2022 Agenda

More MWS EU 2022 Speakers